Latest Insider Transactions at Jazz Pharmaceuticals PLC (JAZZ)
This section provides a real-time view of insider transactions for Jazz Pharmaceuticals PLC (JAZZ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Jazz Pharmaceuticals plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Jazz Pharmaceuticals plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 09
2022
|
Anne O Riordan Director |
SELL
Open market or private sale
|
Direct |
466
-2.4%
|
$69,434
$149.71 P/Share
|
|
May 06
2022
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
296
-0.9%
|
$45,288
$153.92 P/Share
|
|
May 05
2022
|
Christopher J. Tovey EVP, COO & Managing Director E |
SELL
Payment of exercise price or tax liability
|
Direct |
1,096
-6.47%
|
$167,688
$153.22 P/Share
|
|
May 02
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
7,260
-0.41%
|
$1,139,820
$157.13 P/Share
|
|
May 02
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.65%
|
$446,200
$46.83 P/Share
|
|
Apr 05
2022
|
Renee D Gala President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,633
-4.46%
|
$264,546
$162.88 P/Share
|
|
Apr 04
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
10,772
-0.61%
|
$1,701,976
$158.17 P/Share
|
|
Apr 04
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.65%
|
$446,200
$46.83 P/Share
|
|
Mar 17
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,288
+0.37%
|
$75,992
$59.13 P/Share
|
|
Mar 05
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,929
-5.96%
|
$3,355,137
$153.96 P/Share
|
|
Mar 05
2022
|
Renee D Gala President & COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
720
-1.93%
|
$110,160
$153.96 P/Share
|
|
Mar 05
2022
|
Robert Iannone EVP, Global Head of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
1,327
-3.27%
|
$203,031
$153.96 P/Share
|
|
Mar 05
2022
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,228
-3.59%
|
$187,884
$153.96 P/Share
|
|
Mar 05
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,836
-11.62%
|
$280,908
$153.96 P/Share
|
|
Mar 05
2022
|
Kim Sablich EVP, GM of U.S. |
SELL
Payment of exercise price or tax liability
|
Direct |
746
-2.4%
|
$114,138
$153.96 P/Share
|
|
Mar 05
2022
|
Daniel N Swisher Jr President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,802
-7.74%
|
$734,706
$153.96 P/Share
|
|
Mar 03
2022
|
Patricia Carr SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,488
+23.07%
|
-
|
|
Mar 03
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
44,788
+10.86%
|
-
|
|
Mar 03
2022
|
Renee D Gala President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
11,730
+23.9%
|
-
|
|
Mar 03
2022
|
Robert Iannone EVP, Global Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
11,374
+21.89%
|
-
|
|
Mar 03
2022
|
Finbar Larkin SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
4,621
+17.89%
|
-
|
|
Mar 03
2022
|
Neena M Patil EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,886
+20.62%
|
-
|
|
Mar 03
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,839
+19.55%
|
-
|
|
Mar 03
2022
|
Kim Sablich EVP, GM of U.S. |
BUY
Grant, award, or other acquisition
|
Direct |
9,953
+24.25%
|
-
|
|
Mar 03
2022
|
Daniel N Swisher Jr President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
13,507
+17.88%
|
-
|
|
Mar 03
2022
|
Christopher J. Tovey EVP, COO & Managing Director E |
BUY
Grant, award, or other acquisition
|
Direct |
7,820
+31.59%
|
-
|
|
Mar 02
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,000
-1.82%
|
$900,000
$150.0 P/Share
|
|
Mar 01
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,501
-0.65%
|
$884,136
$136.62 P/Share
|
|
Mar 01
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.81%
|
$446,200
$46.83 P/Share
|
|
Feb 01
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,372
-0.64%
|
$885,708
$139.2 P/Share
|
|
Feb 01
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.84%
|
$446,200
$46.83 P/Share
|
|
Jan 03
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
5,791
-0.44%
|
$741,248
$128.08 P/Share
|
|
Jan 03
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.87%
|
$446,200
$46.83 P/Share
|
|
Jan 03
2022
|
Daniel N Swisher Jr President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,624
-3.24%
|
$212,744
$131.01 P/Share
|
|
Dec 02
2021
|
Jennifer E. Cook Director |
SELL
Open market or private sale
|
Direct |
417
-8.62%
|
$50,457
$121.3 P/Share
|
|
Dec 02
2021
|
Mark Douglas Smith Director |
SELL
Open market or private sale
|
Direct |
417
-8.62%
|
$50,457
$121.3 P/Share
|
|
Dec 01
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,748
-1.04%
|
$823,256
$122.72 P/Share
|
|
Dec 01
2021
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.9%
|
$446,200
$46.83 P/Share
|
|
Nov 12
2021
|
Finbar Larkin SVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
197
-1.18%
|
$26,595
$135.79 P/Share
|
|
Nov 11
2021
|
Kim Sablich EVP, GM of U.S. |
SELL
Open market or private sale
|
Direct |
2,748
-11.51%
|
$370,980
$135.01 P/Share
|
|
Nov 01
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,556
-0.68%
|
$878,504
$134.64 P/Share
|
|
Nov 01
2021
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.92%
|
$446,200
$46.83 P/Share
|
|
Oct 04
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,598
-2.07%
|
$851,142
$129.87 P/Share
|
|
Oct 04
2021
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.95%
|
$446,200
$46.83 P/Share
|
|
Sep 08
2021
|
Finbar Larkin SVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
63
-0.38%
|
$8,442
$134.51 P/Share
|
|
Sep 01
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
500
-0.16%
|
$65,500
$131.58 P/Share
|
|
Aug 18
2021
|
Patrick G Enright Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,000
+50.0%
|
$274,000
$137.75 P/Share
|
|
Aug 06
2021
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
157
-2.54%
|
$23,079
$147.96 P/Share
|
|
Aug 06
2021
|
Peter Gray Director |
SELL
Open market or private sale
|
Direct |
1,414
-9.91%
|
$207,858
$147.96 P/Share
|
|
Aug 06
2021
|
Heather Ann Mc Sharry Director |
SELL
Open market or private sale
|
Direct |
1,414
-11.24%
|
$207,858
$147.96 P/Share
|